SOUTH SAN FRANCISCO, Calif., March 30, 2011 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS), a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers, today announced that Daniel Swisher, Chief Executive Officer of Sunesis, will be presenting at the 10th Annual Needham Healthcare Conference on Tuesday, April 5th at 4:00 PM Eastern Time at The New York Palace Hotel in New York City.
